ArticleCell reports2024

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy.

Sunita Keshari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.